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Introduction: Crohn’s disease is an autoimmune inflammatory disorder affecting the
gastrointestinal tract. Rarely, Crohn’s disease can cause cutaneous manifestations that are
non-contiguous with the GI tract or “metastatic.” Genital Cutaneous Crohn’s Disease (CCD)
is the most frequent presentation of CCD in the pediatric population and has shown to be
difficult to manage.
Case: A 13-year-old boy with a history of fistulizing Crohn’s disease presented with severe
penile and scrotal edema for the previous 4 years. While his gastrointestinal symptoms were
responsive to Adalimumab, his genital swelling only minimally and temporarily improved
between treatments. He was referred to pediatric urology for an excisional biopsy which
revealed dermal fibrosis, perilymphatic inflammatory infiltrate composed of lymphocytes,
plasma cells, and histiocytes. Additionally, poorly formed granulomas of histiocytes and
multinucleated giant cells were identified. The scrotal and penile biopsies were both
compatible with the diagnosis of metastatic Crohn’s disease.
Conclusion: We describe a rare case of genital CCD in a patient with well controlled
Crohn’s. After the positive biopsy, the patient began Azathioprine and Adalimumab
combination therapy with substantial improvement in genital swelling. Although there are
no treatment guidelines for CCD, literature suggests combination systemic therapy with
immunomodulators to be the most beneficial. We highlight treatment options.
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Introduction: Lymph node (LN) status is a key prognostic factor in squamous cell
carcinoma of the penis. A multi-disciplinary approach consisting of neoadjuvant
chemotherapy, possible radiation followed by consolidation surgery improves the outcomes
of advanced, and locally invasive penile cancer. Lymphadenoctomy is the mainstay
treatment of node positive penile cancer and may be curative, if not palliative in patients with
lymph node dissection.
Methods: Retrospective chart review was performed.
Case: We herein describe a case of a 51-year-old otherwise healthy Amish male with
SCC of the penis, with a 15 cm soft tissue mass consistent with metastatic penile cancer.
Neoadjuvant (NAC) chemotherapy was initiated, which the patient was unfortunately
unable to tolerate due to toxicity. Follow up MRI revealed enlarging left inguinal LN mass
with invasion into the adductor muscles, with femoral vessel involvement (Figure 1D).
Due to substantial local symptoms and imminent vascular compromise, bilateral inguinal/
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